StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
DXCM

DexCom, Inc.

DXCM Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$87.31
+12.77 +17.13%

Key statistics

from XBRL data in SEC filings
Market cap
$32.9B
Revenue (TTM)
$4.97B
Net income (TTM)
$1000M
EPS (TTM)
$2.52
P/E ratio
34.6
Dividend yield
Free cash flow
$1.08B
Cash
$1.10B
Total assets
$6.46B
Gross margin
62.5%
52-week range
$54.11 – $87.63

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Shareholder vote results May 28, 2026 8-K Regulation FD disclosure; Other events May 15, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Director or officer change Mar 2, 2026 8-K Director or officer change; Regulation FD disclosure Feb 26, 2026 10-K Fiscal year ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Director or officer change Dec 22, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 30, 2025 8-K Director or officer change; Regulation FD disclosure Oct 27, 2025 8-K Director or officer change Sep 16, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Results of operations (earnings release); Director or officer change Jul 30, 2025 8-K Director or officer change May 13, 2025 8-K/A Director or officer change May 9, 2025 8-K Director or officer change; Shareholder vote results May 9, 2025 8-K Director or officer change May 2, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release); Other events May 1, 2025 8-K Changed accountants Mar 25, 2025 8-K Director or officer change; Regulation FD disclosure Mar 10, 2025 8-K Regulation FD disclosure; Other events Mar 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 18, 2025 8-K Results of operations (earnings release) Feb 13, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Entered a material agreement Dec 23, 2024 10-Q Quarter ended 2024-09-30 Oct 24, 2024 8-K Results of operations (earnings release) Oct 24, 2024 10-Q Quarter ended 2024-06-30 Jul 25, 2024 8-K Results of operations (earnings release); Other events Jul 25, 2024 8-K Shareholder vote results May 24, 2024 10-Q Quarter ended 2024-03-31 Apr 25, 2024 8-K Results of operations (earnings release) Apr 25, 2024 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity Feb 15, 2024 10-K Fiscal year ended 2023-12-31 Feb 8, 2024